4.9K
Articles
85.9K
Citations
3.1
avg. Impact Factor
105
h-index

Most Cited Articles of Department of Internal Medicine

TitleJournalYearCitations
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20163.8K
Large-scale association analysis identifies new risk loci for coronary artery diseaseNature Genetics20131.2K
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet, The20171.1K
Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesisArteriosclerosis, Thrombosis, and Vascular Biology2004979
COVID-19: towards controlling of a pandemicLancet, The2020793
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinibJournal of Clinical Oncology2005681
Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trialLancet Oncology, The2014549
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsLancet, The2017543
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinasesCirculation2005516
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease2010493
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United StatesHepatology2013459
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter studyCirculation2012450
The transcriptional landscape and mutational profile of lung adenocarcinomaGenome Research2012435
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trialsJournal of the American College of Cardiology2007431
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung CancerNew England Journal of Medicine2018427
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases ActivityClinical Cancer Research2016397
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II TrialJournal of Clinical Oncology2017366
Darapladib for preventing ischemic events in stable coronary heart diseaseNew England Journal of Medicine2014363
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomesJournal of the American College of Cardiology2014361
Transcutaneous ultrasound energy harvesting using capacitive triboelectric technologyScience2019347
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetesDiabetes Care2006333
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncology, The2017330
A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancerCancer1993323
Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trialsBMJ, The2013305
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialAnnals of Oncology2017296